Symbol
NBY on NYSE
Investment type
Equity / Common Stock, par value $0.01 per share
Latest Disclosed Shares Owned
6,388,000 shares
Security Ownership %
5%

David E. Lazar ownership in NovaBay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY)

29 Jan 2026 - David E. Lazar has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,388,000 shares of NovaBay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY). This represents 5% ownership of the company. In their previous filing dated 17 Oct 2025, David E. Lazar had reported owning 1,502,080 shares, indicating an increase of +325%. .